NEWSLETTER- January 19th, 2015
ABOUT CHEMO DYNAMICS
For more than half a century, Chemo Dynamics has been the power behind the scenes for many pharmaceutical & biotechnology companies. We are a US-based CRO/CMO with a network of manufacturing relationships globally. Our research knowledge and reputation for producing excellent quality products with efficient and fast turnaround times span over five decades. We focus on doing chemistry. Chemo Dynamics has created a few blockbuster IPs for virtual clients. Our key areas of expertise include diabetic care, oncology, metabolic, cardiovascular, eye treatment (glaucoma), and Alzheimer’s and obesity. We are committed to the success of our clients.
OUR BUSINESS MODEL
We are a focused organization that understands that rapid turnaround time and high-quality products are important to our customers. While some vendors specialize in particular areas of chemistry, we focus on doing chemistry.
OUR MISSION
We are eager to become part of your outsource team, providing Custom Synthesis and Process Development while minimizing your time to market. Our people adhere to the highest scientific and ethical standards with the goal of providing the finest customer service in the industry.
WHAT WE OFFER
- Custom Small Scale Synthesis Library and Combinatorial Synthesis
- Synthesis of Biological Importance
- Route Scouting/Selection and Reaction Screening
- Process Research and Robust Process Development
- Process Definition and Characterization
- Analytical Method Development and Characterization
- Full Technology Development with Complete Documentation
- Multi-Kilo Quantities for Late-Stage Development
- GMP and non-GMP Scale-Up to 100 kg and much more as CMO
- Toll Manufacturing through strategic partner associates
- Stability Study
- FTE Option
FACT
Every day that a drug is delayed from going to market can cost a pharmaceutical company $1 million in sales.
In today’s highly competitive environment, pharmaceutical and biotechnology companies are increasingly leveraging their internal assets via external outsourcing of intermediates, combinatorial building blocks, reference standards, and even research projects.